1. Market Research
  2. > Pharmaceutical Market Trends
  3. > Mexico Pharmaceuticals and Healthcare Report Q1 2016

Mexico Pharmaceuticals and Healthcare Report Q1 2016

  • November 2015
  • -
  • Business Monitor International
  • -
  • 78 pages

BMI View

: The government's efforts to improve competitiveness in Mexico's pharmaceutical sectorcombined with the country's economic outperformance over large countries like Brazil in 2015 will improveMexico's attractiveness to drugmakers. As such, Mexico's consumer demand growth has started to pick up,which could be a substantial driver of a more consumer-driven economy. However, overdependence on USeconomic cycles has held down investment in the domestic pharmaceuticals market.

Headline Expenditure Projections

- Pharmaceuticals: MXN172.6bn (USD13.0bn) in 2014 to MXN177.3bn (USD11.4bn) in 2015; +2.8% inlocal currency terms and -12.0% in US dollar terms. Forecast broadly unchanged in local currency termscompared with previous quarter. Forecast revised down in USD due to revised exchange rateexpectations.

- Healthcare: MXN1.1trn (USD80.8bn) in 2014 to MXN1.2trn (USD74.1bn) in 2015; +7.2% in localcurrency terms and -8.3% in US dollar terms. Forecast broadly unchanged in local currency termscompared with previous quarter. Forecast revised down in USD due to revised exchange rateexpectations.

Table Of Contents

Mexico Pharmaceuticals and Healthcare Report Q1 2016
BMI Industry View 7
Table: Headline Pharmaceuticals and Healthcare Forecasts (Mexico 2013-2019) 7
SWOT 9
Industry Forecast 11
Pharmaceutical Market Forecast 11
Table: Pharmaceutical Sales, Historical Data And Forecasts (Mexico 2011-2019) 13
Healthcare Market Forecast 14
Table: Healthcare Expenditure Trends, Historical Data And Forecasts (Mexico 2011-2019) 16
Table: Government Healthcare Expenditure Trends, Historical Data And Forecasts (Mexico 2011-2019) 17
Table: Private Healthcare Expenditure Trends, Historical Data And Forecasts (Mexico 2011-2019) 17
Prescription Drug Market Forecast 18
Table: Prescription Drug Market Indicators, Historical Data And Forecasts (Mexico 2011-2019) 19
Patented Drug Market Forecast 20
Table: Patented Drug Market Indicators, Historical Data And Forecasts (Mexico 2011-2019) 22
Generic Drug Market Forecast 23
Table: Generic Drug Market Indicators, Historical Data And Forecasts (Mexico 2011-2019) 24
OTC Medicine Market Forecast 24
Table: Over-The-Counter (OTC) Medicine Market Indicators, Historical Data And Forecasts (Mexico 2011-2019) 26
Pharmaceutical Trade Forecast 27
Table: Pharmaceutical Trade Data And Forecasts (Mexico 2013-2019) 29
Table: Pharmaceutical Trade Data And Forecasts local currency (Mexico 2013-2019) 29
Industry Risk Reward Index 30
Americas Risk/Reward Index 30
Mexico Risk/Reward Index 37
Rewards 37
Risks 37
Regulatory Review 39
Intellectual Property Issues 40
Pricing Regime 42
Reimbursement Regime 43
Market Overview 45
Healthcare Sector 45
Table: Healthcare Resources (Mexico 2009-2014) 46
Table: Healthcare Personnel (Mexico 2009-2014) 46
Table: Healthcare Activity (Mexico 2009-2014) 47
Table: List Of Hospitals In Mexico With Joint Commission International Accreditation 50
Research And Development 50
Clinical Trials 51
Epidemiology 52
Competitive Landscape 55
Research-Based Industry 55
Table: Multinational Market Activity 56
Generic Drugmakers 57
Pharmaceutical Distribution 58
Pharmaceutical Retail Sector 59
Table: IMSS Financial Indicators, 2000-11 (MXNmn) 60
Company Profile 61
Boehringer Ingelheim 61
Genomma Labs 64
Demographic Forecast 67
Demographic Outlook 67
Table: Population Headline Indicators (Mexico 1990-2025) 68
Table: Key Population Ratios (Mexico 1990-2025) 68
Table: Urban/Rural Population and Life Expectancy (Mexico 1990-2025) 69
Table: Population By Age Group (Mexico 1990-2025) 69
Table: Population By Age Group % (Mexico 1990-2025) 70
Glossary 72
Methodology 74
Pharmaceutical Expenditure Forecast Model 74
Healthcare Expenditure Forecast Model 74
Notes On Methodology 75
Risk/Reward Index Methodology 76
Index Overview 77
Table: Pharmaceutical Risk/Reward Index Indicators 77
Indicator Weightings 78

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Amrita

+1 718 303 2019

Purchase Reports From Reputable Market Research Publishers
PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024

PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024

  • $ 10995
  • Industry report
  • September 2016
  • by Global Data

PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024 Summary Attention deficit hyperactivity disorder (ADHD) is characterized by excessive levels ...

Global Pharmaceutical Contract Manufacturing Organization (CMO) Market

Global Pharmaceutical Contract Manufacturing Organization (CMO) Market

  • $ 7000
  • Industry report
  • August 2016
  • by Frost & Sullivan

Emerging Business Models Drive Transformation The key objective of this research is to provide in-depth knowledge of the major global pharmaceutical CMO market segments—active pharmaceutical ingredients ...

Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation

Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation

  • $ 6995
  • Industry report
  • November 2016
  • by GBI Research

Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation Summary Asthma is a chronic condition affecting ...


ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.